GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Price-to-Free-Cash-Flow

BITGF (Biotage AB) Price-to-Free-Cash-Flow : 50.51 (As of Dec. 12, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Price-to-Free-Cash-Flow?

As of today (2024-12-12), Biotage AB's share price is $14.80. Biotage AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.29. Hence, Biotage AB's Price-to-Free-Cash-Flow Ratio for today is 50.51.

The historical rank and industry rank for Biotage AB's Price-to-Free-Cash-Flow or its related term are showing as below:

BITGF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.13   Med: 44.9   Max: 88.61
Current: 53.21

During the past 13 years, Biotage AB's highest Price-to-Free-Cash-Flow Ratio was 88.61. The lowest was 13.13. And the median was 44.90.

BITGF's Price-to-Free-Cash-Flow is ranked worse than
68.86% of 350 companies
in the Medical Devices & Instruments industry
Industry Median: 32.945 vs BITGF: 53.21

Biotage AB's Free Cash Flow per Share for the three months ended in Sep. 2024 was $0.07. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.29.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Biotage AB was 49.10% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -7.90% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 12.00% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 25.00% per year.

During the past 13 years, Biotage AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 102.00% per year. The lowest was -10.30% per year. And the median was 20.00% per year.


Biotage AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Biotage AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Price-to-Free-Cash-Flow Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.59 41.58 57.75 45.30 51.27

Biotage AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.98 51.27 54.41 50.03 61.78

Competitive Comparison of Biotage AB's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Biotage AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biotage AB's Price-to-Free-Cash-Flow falls into.



Biotage AB Price-to-Free-Cash-Flow Calculation

Biotage AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=14.80/0.293
=50.51

Biotage AB's Share Price of today is $14.80.
Biotage AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Biotage AB  (OTCPK:BITGF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Biotage AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biotage AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB Headlines